Editorial
Copyright ©2010 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 14, 2010; 16(46): 5779-5789
Published online Dec 14, 2010. doi: 10.3748/wjg.v16.i46.5779
Figure 3
Figure 3 Blockades of type I insulin-like growth factor receptor reduce tumor progression through several interruptions of type I insulin-like growth factor receptor-mediated functions, including type I insulin-like growth factor receptor/matrilysin positive feedback system. IGF-IR: Type I insulin-like growth factor receptor; IGFBPs: IGF binding proteins.